Homocysteine, cysteine, and body composition in the Hordaland Homocysteine Study: does cysteine link amino acid and lipid metabolism?
INTRODUCTION
Cystathionine ␤-synthase (CBS) deficiency is the most common cause of homocystinuria (1) . Normally, homocysteine, produced in S-adenosylmethionine-dependent transmethylation reactions, is either remethylated to methionine or irreversibly metabolized to cysteine by the action of CBS and cystathionase enzymes (2) . CBS deficiency therefore leads not only to upstream accumulation of homocysteine and methionine but also to reduced synthesis of cystathionine and cysteine (3) .
The characteristic phenotype of the disorder includes vascular, neurologic, ocular, and skeletal abnormalities (1) . Common skeletal abnormalities include marfanoid features, dolichostenomelia (unusually long, thin extremities), osteoporosis, and arachnodactyly (1, 4) . In addition, patients are reported to have a thin build (1), low subcutaneous fat (5) , and low body mass index (BMI; in kg/m 2 ), as calculated from Brenton et al (4) .). The cause of skeletal changes is unknown. Impaired cross-linking of collagen as a result of hyperhomocysteinemia has been suggested, but the evidence is insufficient (6) . Notably, skeletal changes have not been reported in patients with inborn errors of homocysteine remethylation, who also have severe hyperhomocysteinemia but who synthesize normal amounts of cysteine (7) . Despite this, the role of decreased cysteine synthesis in the pathophysiology of skeletal changes in CBS deficiency has received little attention.
Plasma total cysteine (tCys) has been shown to be strongly related to BMI in the Hordaland Homocysteine Study (HHS) (8) . Moreover, changes in tCys over a 6-y period were positively associated with changes in BMI (9) . Although the tCys-BMI association was conventionally interpreted as indicating that BMI was a determinant of tCys, the evidence from homocystinuria due to CBS deficiency (1, 4, 5) suggests that the reverse may be true. In CBS-deficient subjects, the pathologic condition most likely proceeds from the primary abnormal concentrations of the aminothiols, including low tCys, to the skeletal manifestations and the thin phenotype.
Whereas it is possible that elevated plasma total homocysteine (tHcy) may also determine body composition, evidence on an association of tHcy with BMI in the general population has been conflicting. Most cross-sectional studies report weak-positive (10 -12) or no (13) associations between BMI and tHcy, but clinical trials have found weight loss to be associated with an elevation of tHcy (14 -16) , even without a lowering of serum folate or vitamin B-12 (14) . Similarly inconsistent associations have been observed between tHcy and total-body (TB) lean mass (17, 18) and fat mass (18, 19) .
In the present study, we raised the hypothesis that tHcy, tCys, or both are associated with body composition in the general population. Using data from the HHS, we examined the relations between tCys, tHcy, and BMI in 7038 subjects and between these aminothiols and TB lean mass and fat mass in 5179 subjects.
SUBJECTS AND METHODS

Study population
The first HHS (HHS-I) was conducted in 1992 and 1993 on 18 043 middle-aged (40 -42-y-old) or elderly (65-67-y-old) residents of Hordaland county in western Norway. From 1997 through 1999, a follow-up study (HHS-II) of participants living in Bergen and its surroundings was conducted as part of the Hordaland Health Study. In HHS-II, 9187 of the HHS-I subjects were invited to return, of whom 7074 (77%) attended: 3341 elderly subjects (then aged 71-73 y) and 3733 middle-aged subjects (then aged 47-48 y) (20) .
This study is based on data from HHS-I and HHS-II. For 7038 subjects, information was available on BMI, plasma tHcy, tCys, and total cysteinylglycine (tCysGly) in both HHS I and II. We examined the cross-sectional association between tHcy, tCys, and BMI by using data from HHS-II. The relation of tHcy and tCys with TB lean mass and TB fat mass was examined in 5179 HHS-II participants in whom fat mass and lean mass were measured. We also investigated the association of changes in tCys and tHcy over the 6-y period with BMI, lean mass, and fat mass at follow-up.
For 3516 of the HHS-II participants (including 2894 elderly), nonfasting plasma concentrations of cystathionine and methionine were measured. Body composition data were available for 2696 of these participants (including 2083 elderly), whereas BMI data were available for all. Using these data, we tested whether the associations of tCys with body composition remained robust after adjustment for variations in cystathionine and methionine. Because the measurements of these aminothiols were nonfasting, and because these measurements are known to vary with food intake (21), analyses involving cystathionine and methionine were adjusted for time since last meal.
All subjects provided written informed consent. Study protocols for HHS-I and HHS-II were approved by the Regional Committee for Medical Research Ethics Ethical Committee of Western Norway, whose directives are based on the Helsinki Declaration.
Study variables BMI, body composition, and blood pressure
Height and weight were measured while subjects were wearing light clothing, and BMI was calculated. Seated arterial blood pressure was measured 3 times in each subject; the average of the second and third measurements was used.
Lean mass and fat mass were measured by using dual-energy X-ray absorptiometry (DXA) (22) , which is based on the different attenuation of photons by different body tissues. Transmission of X-rays at 2 energy levels allows the derivation of TB bone mineral mass, lean mass, and fat mass. Measurements were done on a stationary fan-beam densitometer using EXPERT-XL software (version 1.72-1.9; Lunar Corporation, Madison, WI). The CVs for lean mass and fat mass were 1.3% and 1.9%, respectively.
Lifestyle and dietary data
Self-administered questionnaires provided information on diet (23) and lifestyle. Nutrient intakes were calculated by using KOSTBEREGNINGSSYSTEM software (version 3.2; Department of Nutrition, University of Oslo, Oslo, Norway). Physical activity included 2 variables indicating heavy or light physical activity in the past year, and each variable comprised 4 categories: 1) none, 2) ͨ1 h/wk, 3) 2-3 h/wk, and 4) 4 h/wk. Smoking and coffee consumption were used as continuous variables comprising the number of cigarettes smoked per day or the cups of coffee consumed per day.
Biochemical measurements
Nonfasting plasma samples were collected in EDTAcontaining tubes for analyses of tCys, tHcy, tCysGly, folate, and vitamin B-12 as described previously (24) . Plasma tHcy, tCys, and tCysGly were analyzed by using HPLC with fluorescence detection. The intraassay CV was 4% (25) . Liquid chromatography-tandem mass spectroscopy was used for analyzing methionine and cystathionine as described previously (26) . Plasma folate and vitamin B-12 were measured by using microbiological assays (27, 28) . Serum HDL cholesterol (from HHS II only), triacylglycerol, and total cholesterol were measured at the Department of Clinical Chemistry (Ullevål Hospital, Oslo, Norway) by using enzymatic methods. Creatinine (from HHS II only) was measured in stored plasma by using a modification of a liquid chromatography-tandem mass spectroscopy described previously (29) .
Statistical analysis
Despite statistically significant tCys ҂ sex interactions for BMI and fat mass (stronger in women than men) and statistically significant tHcy ҂ age interactions for BMI (stronger in younger than in older subjects), stratified analysis showed only modest differences in the patterns and strengths of these associations between middle-aged and elderly men and women. Unless otherwise stated, we therefore combined the 4 age-sex groups with adjustment for age and sex.
One-way ANOVA and chi-square tests with Bonferroni correction were used to determine significant differences between groups, and simple correlations were assessed by using Spearman's rank correlation coefficient. Skewed variables were logtransformed before analysis. Multiple linear regression models were used to assess the role of tCys and tHcy as determinants of BMI, lean mass, and fat mass. Adjustments were made for variables associated with tCys (8) or tHcy (20) that are potentially related to body build and for related metabolites including cystathionine, methionine, and tCysGly.
To show nonlinear relations, dose-response curves were constructed to show the estimated difference in tCys by tHcy and in BMI, lean mass, and fat mass by tCys and tHcy. We used Gaussian generalized additive regression models, as implemented in S-PLUS for WINDOWS software (version 6.2; Insightful Corporation, Seattle, WA). On the y-axis, the model generates a reference value of zero that approximately corresponds to the value of BMI, lean mass, or fat mass associated with the mean tCys or tHcy for all subjects. Various models with different covariates are specified in the figure legends. Corresponding P values were obtained from multiple linear regression analyses.
To assess the effect of changes in tCys or tHcy over 6 y as predictors of BMI, fat mass, or lean mass at follow-up, multiple linear regression models were used. BMI, fat mass, or lean mass at follow-up was used as the dependent variable, whereas changes in tHcy or tCys over 6 y were represented in the models as indicator variables, denoting membership to 1 of the 5 quintiles for changes in tCys or tHcy. Thus, each regression coefficient estimated the difference in BMI, fat mass, or lean mass between the lowest quintile (reference) and the other 4 quintiles of changes in tHcy or tCys.
All statistical analyses, except dose-response curves, were performed by using SPSS for WINDOWS software (version 12.0; SPSS Institute, Chicago. IL). Tests of significance were 2-tailed, and P 0.05 was considered significant.
RESULTS
Characteristics of the study population
Selected population characteristics are shown in Table 1 . BMI was significantly (P 0.001) higher in middle-aged men than in women, although men had significantly (P 0.001) lower fat mass than did women. The ratio of fat mass to lean mass differed significantly (P 0.001) among the 4 age-sex groups, increasing from middle-aged men to elderly men to middle-aged women to elderly women. With the use of Spearman correlations, lean mass and fat mass were positively associated (r s ҃ 0.28, P 0.001 in men; r s ҃ 0.37, P 0.001 in women). The correlation of directly measured body weight with the sum of body-composition elements as obtained by DXA (lean mass ѿ fat mass ѿ bone mineral content) was almost perfect (r s ҃ 0.98). Mean plasma tCys, tHcy, and creatinine were significantly (P 0.001) higher in the elderly than in the middle-aged and significantly (P 0.05) higher in men than in women of the same age group.
Relation of total homocysteine and total cysteine
Linear regression analysis showed a significant positive association between tHcy as a determinant variable and tCys as dependent variable, after adjustment for age and sex (partial r ҃ 0.37, P 0.001; Figure 1A ), and this association was unchanged by adjustment for folate, vitamin B-12, creatinine, fat mass, and lean mass (data not shown). From low to high tHcy concentrations, tCys differed by Ȃ60 mol/L, although, toward the higher tHcy values, tCys concentrations leveled off. Change in tHcy over 6 y was linearly associated with change in tCys in the same direction (partial r ҃ 0.32, P 0.001; Figure 1B ), with adjustment for age and sex. Because of this strong relation between tHcy and tCys, the linear regression analyses were always performed both with and without reciprocal adjustment for tCys and tHcy.
Total cysteine and indexes of body mass tCys and BMI
The association between tCys and BMI, after control for age and sex, was linear, highly significant (partial r ҃ 0.28, P 0.001; Figure 2A ), and not affected by adjustments for tHcy (partial r ҃ 0.29, P 0.001 for tCys) or plasma creatinine, lipids (ie, total cholesterol, triacylglycerol, and HDL), coffee intake, or systolic blood pressure (partial r ҃ 0.26, P 0.001 for tCys). In a model fully adjusted for age, sex, tHcy, creatinine, lifestyle factors (eg, coffee intake, smoking, and physical activity), nutritional intake (ie, total energy, protein, and fat intakes), and serum lipids, tCys was the strongest determinant of BMI (partial r ҃ 0.23, P 0.001).
Total cysteine and body composition
There was no effect of tCys on lean mass when fat mass was taken into account, and the dose-response curves were essentially horizontal with (partial r ҃ 0.02, P ҃ 0.10) and without (r ҃ 0.02, P ҃ 0.20; Figure 2B ) adjustment for tHcy. There was a strong positive linear association between tCys and fat mass, after control for age, sex, and lean mass (partial r ҃ 0.26, P 0.001; Figure 2C ). This association was largely unaffected by adjustment for tHcy, plasma creatinine, total cholesterol, triacylglycerol, HDL, coffee intake, and systolic blood pressure (partial r ҃ 0.25, P 0.001 for tCys). In this latter model, tCys was the strongest plasma determinant of fat mass, followed by HDL (partial r ҃ Ҁ0.21, P 0.001) and triacylglycerol (partial r ҃ 0.1, P 0.001). In a fully adjusted model, including age, sex, lean mass, and lifestyle (eg, coffee consumption, smoking, and physical activity), nutritional (ie, total energy, protein, and fat intakes), and plasma (ie, creatinine, lipids, and tHcy) variables, tCys was second only to sex and lean mass as a determinant of fat mass (partial r ҃ 0.21, P 0.001 for tCys).
Lean mass, fat mass, and anthropometric measures by quintiles of tCys in men and women are shown in Table 2 . Women in the highest quintile of tCys had an average weight, fat mass, and waist circumference that were 11 kg (95% CI: 10, 12 kg), 9 kg (8, 10 kg), and 9 cm (8, 10 cm), respectively, higher than those Plasma total cysteine (µmol/L) 
Lean mass (kg)
Fat mass (kg) FIGURE 2. Association of plasma total cysteine with BMI, total-body lean mass, and total-body fat mass. All graphs were obtained by Gaussian generalized additive regression models and were adjusted for age and sex. Additional adjustments include fat mass (B) and lean mass (C). P values were obtained by corresponding linear regression analyses. The lowest and highest 1 percentiles of independent variable are not shown.
Estimated differences
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Change in tCys (µmol/L) FIGURE 1. Dose-response curves (solid lines) with 95% CIs (shaded areas) for associations of plasma total homocysteine (tHcy) with plasma total cysteine (tCys) and of change in tHcy during 6 y with change in tCys. Curves were fitted by Gaussian generalized additive regression models and were adjusted for age and sex. P values were obtained by corresponding linear regression analyses. The lowest and highest 1 percentiles of independent variables are not shown.
in women in the lowest quintile. In men, the corresponding values were 7 kg (6, 8 kg), 6 kg (5, 7 kg), and 6 cm (5, 7 cm), respectively (P 0.001 across quintiles in men and women, ANOVA). Waist and hip circumferences and waist/hip ratio also increased significantly across tCys quintiles. In contrast, height showed only a minor fluctuation of up to 1 cm between the tCys quintiles, and there was no apparent trend.
Change in tCys over a 6-y follow-up period was associated with significant differences in BMI and fat mass, with a negligible effect on lean mass. Estimated differences in BMI, fat mass, and lean mass at follow-up by quintiles of change in tCys compared with first quintile, after adjustment for various covariates, are shown in Table 3 . The group of participants with the highest increase in tCys had fat mass at follow-up that was 2 kg greater 1 All values are x ; 95% CI in parentheses. Quintiles are age group-and sex-specific. Significance of difference between quintiles was first tested by ANOVA (P 0.001 for all variables except height in men) followed by group-wise comparisons with Bonferroni adjustment using the lowest quintile as reference.
2 P 0.05 compared with first quintile. 3 P 0.001 compared with first quintile.
TABLE 3
Estimated differences in BMI, lean mass, and fat mass at follow-up by quintile (Q) of change in total cysteine (tCys) and total homocysteine (tHcy) over 6 y 1 The models were calculated by linear regression and estimated the difference in mean BMI, fat mass, and lean mass between each quintile and the reference quintile (lowest quintile) of change in tCys or tHcy. Models 1 (left-hand column under each heading) and 2 (right-hand column under each heading) were used for tCys; models 3 (left-hand column under each heading ) and 4 (right-hand column under each heading) were used for tHcy. Model 1: adjusted for age, sex, baseline BMI, baseline tCys, fat mass in case of lean mass, and lean mass in case of fat mass. Model 2: adjusted for all model 1 variables ѿ changes in plasma total cholesterol and triacylglycerol, change in smoking habits, and systolic blood pressure ѿ plasma creatinine and physical activity at follow-up. Model 3: adjusted for age, sex, baseline BMI, baseline tHcy, fat mass in case of lean mass, and lean mass in case of fat mass. Model 4: adjusted for all model 3 variables ѿ changes in plasma concentrations of tCys, vitamin B-12, folate, triacylglycerol, and cholesterol; change in smoking habits; and plasma creatinine and physical activity at follow-up.
than that in the reference category (P for trend 0.001), with adjustment for baseline tCys.
Total homocysteine and indexes of body mass
Total homocysteine and BMI
After control only for age and sex, linear regression analysis showed a weak positive association between tHcy and BMI (partial r ҃ 0.04, P ҃ 0.002; Figure 3A) , which weakened after adjustment for creatinine (partial r ҃ 0.03, P ҃ 0.039). With adjustment for tCys, a significant negative association of tHcy and BMI was found (partial r ҃ Ҁ0.08, P 0.001; Figure 3B ). This association was strengthened by adjustment for plasma concentration of B vitamins (folate and vitamin B-12) as well as lifestyle factors (ie, smoking, physical activity, and coffee consumption), nutritional factors (ie, total energy, protein, and fat intakes) and serum lipids (partial r ҃ Ҁ0.13, P 0.001).
Total homocysteine and body composition
The associations of tHcy as an independent variable with fat mass or lean mass as the outcome in various models were weak. A nonsignificant trend toward an inverse association between tHcy and lean mass, with adjustment for age, sex, and fat mass ( Figure 3C,D) , reached statistical significance only when after adjustment for creatinine (partial r ҃ Ҁ0.03, P ҃ 0.026). However, with further adjustment for tCys, B vitamins, lifestyle factors (ie, smoking, coffee consumption, and physical activity), and nutritional intakes (ie, total energy, protein, and fat intakes), Association of plasma total homocysteine with BMI, lean mass, and fat mass. All graphs were obtained by Gaussian generalized additive regression models and were adjusted for age and sex. Additional adjustments include plasma total cysteine (B), fat mass (C), fat mass and total cysteine (D), lean mass (E), and lean mass and total cysteine (F). P values were obtained by corresponding linear regression analyses. The lowest and highest 1 percentiles of independent variables are not shown. the association of tHcy and lean mass was not significant (partial r ҃ Ҁ0.03, P ҃ 0.085).
The tHcy-fat mass association in the simple linear regression model after adjustment for age, sex, and lean mass was positive (partial r ҃ 0.05, P 0.001; Figure 3E ) and became inverse after control for tCys (partial r ҃ Ҁ0.05, P 0.001; Figure 3F ). Further adjustment for lifestyle variables (ie, smoking, coffee intake, and physical activity), nutritional factors (ie, total energy, protein, and fat intakes), serum lipids, and plasma B vitamins strengthened this inverse tHcy-fat mass association (partial r ҃ Ҁ0.1, P 0.001).
There was no significant association between change in tHcy over a 6-y follow-up period and BMI, lean mass, and fat mass at follow-up (Table 3) . After the inclusion of additional covariates in the models, the associations with BMI and fat mass turned inverse and became statistically significant. The covariate reversing the direction of the association in the fully adjusted models was tCys, which is consistent with its strong correlations both with tHcy and with BMI and fat mass (Figures 1 and 2 ).
Other plasma sulfur amino acids
We investigated whether plasma concentrations of other aminothiols involved in the cysteine metabolic pathway could explain the strong association of tCys with fat mass. A multiple linear regression model examined the roles of tCys, tHcy, cystathionine, methionine, and tCysGly as predictors of fat mass after adjustment for age, sex, lean mass, and time since last meal. tCys remained the strongest aminothiol determinant (partial r ҃ 0.25, P 0.001), followed by cystathionine (partial r ҃ 0.1, P 0.001). Methionine and tHcy showed weak inverse associations with fat mass (partial r ҃ Ҁ0.04, P ҃ 0.038, and partial r ҃ Ҁ0.05, P ҃ 0.011 respectively), whereas tCysGly showed no significant association (partial r ҃ 0.03, P ҃ 0.161). With further adjustment for plasma lipids, only tCys (partial r ҃ 0.24, P 0.001), cystathionine (partial r ҃ 0.05, P ҃ 0.011), and tHcy (partial r ҃ Ҁ0.06, P ҃ 0.002) remained significantly associated with fat mass.
DISCUSSION
Homocystinuria due to CBS deficiency is characterized by extremely elevated tHcy concentrations combined with low tCys concentrations (1), and it leads to a thin phenotype (1, 4, 5) . On the basis of data from the HHS presented here and previously (8, 9), we suggest that more modest variations in these 2 amino acids, particularly tCys, could have an effect on body composition in the general population.
Total cysteine and indexes of body mass
Unlike homocysteine, cysteine is proteinogenic, with a key role in maintaining protein structure and folding (2) and varied functions in cell growth and survival (30) . The sulfur amino acid content of diet correlates strongly with food conversion efficiency (g body wt gain/g food intake) (31) . Yet, in the present study, tCys showed no association with lean mass but a strong positive association with fat mass. As a determinant of fat mass, tCys was even stronger than serum lipids such as triacylglycerol, HDL, and total cholesterol. Thus, our data suggest that decreased tCys may explain the thinness (1), low BMI (4), and decreased subcutaneous fat (5) seen in patients with homocystinuria due to CBS deficiency. In view of the positive influence of fat mass on bone mineral density (32) , it is conceivable that the decreased fat mass may also contribute to osteoporosis in these patients (1) . More important, our data raise the possibility that high tCys or a related factor is causally related to body fat and obesity in the general population.
The transsulfuration pathway is important in meeting metabolic needs for cysteine (2)-and hence the low plasma tCys concentrations seen in CBS deficiency (1) . Diverse evidence suggests an impairment of lipid metabolism in CBS deficiency (33) . Besides the reported low subcutaneous fat (5), there is often a notable absence of arterial lipid deposition, despite extensive vascular pathology (1), fatty liver (1, 5) , and decreased plasma concentrations of triacylglycerol and total cholesterol (34) . Methionine and cystathionine concentrations also are altered in CBS deficiency (26) . However, our results do not suggest a major role for these amino acids in body composition, although this may need to be confirmed by using fasting samples.
A literature search for mechanisms associating tCys with lipid metabolism retrieved no conclusive explanation but several potential links, which we will discuss briefly. One possibility is that high tCys in obese persons is merely a marker for reduced oxidation of cysteine to taurine and hence taurine deficiency, which is believed to result in obesity (35) .
Cysteine is also the precursor of glutathione, the excess of which is cleaved by gamma-glutamyl transferase (GGT) into its constituent amino acids (36) . GGT is thus critical in maintaining the availability of cysteine (36) . In contrast, GGT correlates directly with BMI, central adiposity, and plasma triacylglycerol, LDL, and total cholesterol concentrations (36) . Whether these associations are mediated through GGT's role in maintaining plasma tCys is a question for further study.
Several mechanisms link cysteine to increased energy production. In rat liver, cysteine suppresses 3-phosphoglycerate dehydrogenase, which initiates serine synthesis from 3-phosphoglycerate (37) . Excess 3-phosphoglycerate can thus be diverted toward oxidative energy production in the Krebs cycle. Moreover, cysteine itself is gluconeogenic, but only under conditions of increased cysteine availability, as shown by the conversion of labeled dietary cysteine to glucose in rats (38) . In addition, ␣-ketobutyrate, a byproduct of cysteine formation via transsulfuration, is ultimately metabolized to CO 2 (39) , which raises the question of whether tCys is a marker for an association of ␣-ketobutyrate with energy production. However, in the present study, the tCys-fat mass association was unrelated to plasma lipids and thus was possibly independent of a general positive energy balance.
Cysteine is also utilized in the synthesis of coenzyme A (CoA) (40) . Experiments on perfused rat hearts have shown that exogenous cysteine enhances CoA synthesis (40) , and that a high CoA concentration enhances the incorporation of free fatty acids into triacylglycerol (41) . It is interesting that CoA deficiency resulting from reduced pantothenic acid intake in chicks decreased lipid synthesis and deposition and markedly decreased total body fat (42) . Yet CoA plays a role in fat oxidation as well as in synthesis (43) , and the ways in which cysteine affects these processes in humans remain to be determined.
Finally, insulin promotes fat synthesis and storage, and inhibits the hydrolysis of adipose tissue triacylglycerol (44) . Several (44 -47) but not all (48) studies describe various positive effects of cysteine or its analogue, N-acetylcysteine, on insulin function, which suggests that cysteine can modulate body fat by augmenting or mimicking insulin action.
Total homocysteine and indexes of body mass
The inverse association between tHcy and BMI we observed after adjustment for tCys is supported by findings from previous prospective studies ( 14 -16) and one large cross-sectional study (49) but are not in line with the findings of most cross-sectional studies (10 -12) . However, the cross-sectional studies have not considered the possible confounding effect of tCys, which correlates positively with both tHcy and BMI (8) . Associations of tHcy with lean mass and fat mass in the dataset in the present study were modest but generally negative. A negative association of tHcy with both fat mass and lean mass during weight loss has been reported (18) . Conversely, in other studies, tHcy correlated positively with fat mass (19) and lean mass (17, 50) .
The relation between tHcy and lean mass is complex and likely to involve opposing factors. A high lean mass entails high creatine turnover, with subsequently enhanced homocysteine formation (51). However, dietary creatine intake partly obviates the need for creatine synthesis (51) , which may explain the absence of an association in the population in the present study. Furthermore, tHcy unfavorably correlates with lower body muscle strength and gait speed (52, 53) and is linked to less calf muscle density (54) . Moreover, muscle weakness and electromyographic evidence of myopathy have been shown in homocystinuria (55) . Hence, inconsistent results in different studies may be due to differences in diet, physical activity, or health status as well as to tHcy concentrations.
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